Jump to Navigation
Trends and Sentiments
Comments and Analysis
Visa Inc: Visa Europe Option May Cost More Than $10...
Bury Lenin's Body And The Rest Of Communism: In Red...
Streaming Video Cheat Sheet: 25 Acclaimed 2014 Releases...
How Hedge Fund Managers Lower Their Tax Bills
Cable News Channel Fusion Searches For Its Audience
Metal trading regulation faces challenge
I Asked 20,000 Doctors About Fitbit And Apple's...
Oil price seen falling to $60 if OPEC does not cut output
Fund boards on high alert due to this
Acclaimed 2014 Releases On Netflix Instant
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
Women not equal to men: Turkey's Erdogan
Futures Poised For New Record Highs On Weekend...
EUR/GBP: 1.2643 USD/EUR: 1.241 JPY/USD: 118.2825
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions